Basics: short version, verdict first People Molecules Peptides Biomarkers Studies Stem Cells Editorial Methodology
Layer 1 · Decision
← All products
NOVOS Labs

NOVOS Boost

NAD+ booster · Capsule · 30 servings

Label snapshot

What the label says

What the product contains and what one serving costs, according to our catalog. Label amounts are not personal dose recommendations.

Precursor per serving
NMN 500 mg
Form
Capsule
List price (catalog, USD)
$59.00
Price per serving
$1.97List price divided by servings per container. A per-day cost only if the label serving is once daily.
Full label record: servings, testing, ingredients
Servings per container
30
Serving size (label)
0.5 g
Catalog monthly estimate
$59.00
Testing disclosure
Brand lists third-party testing; no public lab certificate listedStatus as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Ingredients as listed

IngredientAmount per serving
NMN500 mg

What to check on the label

  • Which precursor is named. NMN and NR are different molecules and are not interchangeable milligram for milligram.
  • Whether the milligram figure is per capsule or per serving of several capsules. The catalog records per serving.
  • Whether a certificate of analysis (CoA) is published for the batch you buy. The catalog only records whether the brand lists one.
  • Added ingredients (resveratrol, TMG, quercetin) are listed with their own amounts below. Read them separately.

Amounts are per label serving as recorded in the catalog and are not a recommendation. Testing status reflects what the brand lists. Nothing here is medical advice.

Editorial score and research-dose calculations

These calculations describe our scoring method. They are not a recommended dose or proof of benefit from this product.

7.4/10
Overall score
#21 / 52 in NAD+ booster

Full trial dose, tested by independent lab.

Read the evidence (3 studies)
Add to compareVisit brand site →
Watch outEU restricted1 ingredient restricted in the EU
  • NMN — Unauthorised Novel Food; EFSA positive safety opinion adopted 4 March 2026 at up to 300 mg/day (β-NMN, EffePharm dossier). Commission listing pending.
You can legally buy these outside the EU. Sale as a food supplement inside the EU requires a Novel Food authorisation these ingredients do not have.
Tier 3
Ingredient RCT (matching dose)
The ingredient was tested in an RCT at the same dose this product sells.
See the 3 supporting studies
  • Uthever RCT 2022 (NMN)In 66 adults aged 40-65 over 60 days, NMN (300 mg/day) increased serum NAD+/NADH by 38% versus baseline and improved SF-36 quality-of-life scores compared to placebo. Studied at 300 mg. This product: 500 mg.
  • Yi et al. 2023 (GeroScience) (NMN)In an 80-person, 60-day dose-dependent RCT, oral NMN (up to 900 mg/day) significantly raised blood NAD+ levels, was safe and well-tolerated, and improved six-minute walking distance versus placebo. Studied at 900 mg. This product: 500 mg.
  • Okabe et al. 2022 (Frontiers in Nutrition) (NMN)A 30-person, 12-week RCT found 250 mg/day oral NMN significantly increased whole-blood NAD+ levels with no adverse effects. Studied at 250 mg. This product: 500 mg.
How we scored this product Show the full breakdown
Dose vs. studies (50%) Why 8.0 of 10. Primary ingredient is NMN (evidence grade B). It delivers 500 mg, inside the studied range of 250–900 mg. Read the rule → 8.0
Transparency (20%) Why 7.0 of 10. Earned points for independent third-party testing and all doses disclosed. Lost points for no public certificate of analysis. Read the rule → 7.0
Value (10%) Why 7.3 of 10. One day at the trial dose costs about $1.97. That is more expensive than average (192 of 313 by cost per effective day). Read the rule → 7.3
Formulation (10%) Why 5.0 of 10. No published absorption advantage or disadvantage on file. The default of 5 is not a criticism. Read the rule → 5.0 Default. No absorption data on file.
Safety (5%) Why 7.0 of 10. Baseline 5.0. Third-party testing adds 2.0. Public lab certificate adds 1.5. NSF, USP or Informed Choice certification adds 1.5. Active safety signal subtracts 3.0. Read the rule → 7.0
Community sentiment (5%) Why 8.1 of 10. Sentiment across 7 external review source(s) is mostly positive. Community is a signal about daily use, not proof of effect. Read the rule → 8.1
Composite How this 7.4 is built. 0.50 × 8.0 + 0.20 × 7.0 + 0.10 × 7.3 + 0.10 × 5.0 + 0.05 × 7.0 + 0.05 × 8.1 = 7.4 out of 10. Safety caps applied after. 7.4
7.4 composite
Dose vs. studies50%8.0
Transparency20%7.0
Value10%7.3
Formulation10%5.0
Safety5%7.0
Community5%8.1

Evidence gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Safety caps applied after weighting.

This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.

Read the full method →

Editorial verdict

Quick verdict

7.4 / 10
Best for
Full trial dose
Avoid if
No public lab certificate
Full-dose status
Meets trial dose
Price/month
$59
COA status
Not public
Biggest caveat
No public lab certificate available for independent verification.
Nearest alternatives
Catalog snapshot. Check linked sources for current price, label and batch-specific testing.
Price verification
Current price: $59.00
Last price check: Sep 01, 2026
Add to compareVisit brand site →
Layer 2 · Context

Our summary

NOVOS Boost is a straightforward, single-ingredient NMN capsule, and its default 250 mg/day serving happens to match the dose used in the two most credible human NMN trials (Yoshino 2021 in Science, and Igarashi 2022), both of which showed real, measurable increases in NAD+-related metabolites and modest metabolic benefits over 10-12 weeks. That's a genuine point in its favor. However, several of the more eye-catching claims on NOVOS's own product page — like a 67% jump in endurance or a 90% increase in telomere length — either apply to studies that used 2.4x to 3.6x higher NMN doses than what's in the standard 2-capsule serving, or could not be independently traced to a verifiable source at all. Buyers taking the labeled dose should expect NAD+-related biomarker changes broadly consistent with the matching-dose research, not the more dramatic performance or telomere outcomes NOVOS highlights from higher-dose or unverified studies. At 250 mg/day, NOVOS Boost also delivers a meaningfully lower NMN dose than some direct competitors that dose at 1,000 mg/day, which matters if a buyer is specifically trying to replicate the higher-dose research.
In plain language

Why this scored this way

This NOVOS Labs NOVOS Boost scores 7.4, making it a mid-tier product with both strengths and weaknesses. It delivers 500mg of NMN, inside the studied range of 250–900mg with grade B evidence (promising human data, not yet comprehensive). At $1.97/day it's among the more expensive options in NAD+ booster.

What drives the score up

  • Dose-evidence score of 8.0 reflects good alignment with trial doses.
  • Tested by independent lab (transparency 7.0).
  • Community score of 8.1 with positive consumer feedback.
  • NMN is dosed at the full research level with grade B evidence (promising human data, not yet comprehensive).

What drags it down

  • No public lab certificate available for independent verification.
  • At $1.97/day it's on the expensive side.

Why you'd choose it

  • You want NMN from a NOVOS Labs product.
  • You want a tested by independent lab product.
  • You want doses that align with published research.

Why you might skip it

  • You want a product with a publicly available CoA.
  • You want a cheaper option (this is $1.97/day).
Question 1

Does the molecule work?

The science behind each active ingredient, independent of which brand sells it.

NMN

A NAD+ building block that has become the most-hyped longevity molecule.

5 landmark RCTs · US: FDA reversed exclusion 29 September 2025; NDIN 1247 and NDIN 1259 reinstated 2 December 2025; NDIN 1444 (β-NMN, Effepharm) response 28 January 2026. NMN is a dietary ingredient again; each marketer still needs NDIN coverage. · EU: Unauthorised Novel Food; EFSA positive safety opinion adopted 4 March 2026 at up to 300 mg/day (β-NMN, EffePharm dossier). Commission listing pending.
Question 2

Is this bottle good?

The specific product: dose, price, transparency, and what buyers report.

Dose vs research
100% of trial dose
Meets or exceeds the published effective dose
Cost at trial dose
$1.97/day at trial dose
What one effective daily dose actually costs
Transparency
7.0/10 · No public lab certificate
Independent batch testing confirmed
Consumer signals
No consumer signals collected yet
Operational signal only, never used as clinical evidence
Question 3

What's the catch?

Safety flags, transparency gaps, dosing concerns, and recurring buyer complaints.

No public lab certificate
Certificate of Analysis not published
Without a public lab certificate, batch purity and potency cannot be independently verified.
Plain English

What’s inside

The main ingredients of this product, in plain language.

NMN500 mgEvidence B

A NAD+ building block that has become the most-hyped longevity molecule.

Read about NMN →
Layer 3 · Evidence vault

Product data & verification

Hard numbers and independently checked status. Expand each block for its source.

The numbers

Price
$59
per bottle · 30 servings
Dose vs. research
of trial dose 100%
of published effective dose
$ / day at studied dose
$1.97
what one effective daily dose costs
$ / g active
$3.93
per gram of active substance
Independently checked

Data verification

COA status
Not public
Evidence grade
B
Per-ingredient breakdown
BNMN

All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Evidence grades are reviewed when new human RCTs are published. Read how we verify.

What's inside

Ingredient
Dose in this product
Trial dose
Evidence
NMN
A NAD+ building block that has become the most-hyped longevity molecule.
Yi et al. 2023 (GeroScience)Okabe et al. 2022 (Frontiers in Nutrition)Uthever RCT 2022
500 mg 100% of trial dose
500 mg
4.0 /5
High confidence
2,762 reviews across 3 platforms (3 sources)
Source diversity: 69%
NOVOS Labs (brand site)RedditTrustpilot
Last checked: 2026-08-20

Consumer signals

Consumer signals gathered from 3 platforms.

Low confidence, small sample

Consumer sentiment compiled from 1 public source (Reddit). Small sample size, treat as directional only.

Reddit

1 thread discussed · mixed sentiment

Themes

Fine as a standard NMN; users often compare it to DoNotAge and ProHealth for price.

Compiled from a Reddit r/longevity listing located during manual research; not independently re-verified against the live page at build time.

Trustpilot

108 reviews · 3.7/5

NOVOS Labs (brand site)

2,654 reviews · 4.7/5

These are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.

What others say, with a source hierarchy

We treat external opinion very differently depending on where it comes from. Tier A is our strongest signal. Tier C is background sentiment only. Tier Rejected is what we excluded, listed openly so you can see what we discarded.

These reviews are aggregated from third-party sources, not written by NO1GEVITY. Each entry shows its source, retrieval date, and whether the source has an affiliate or paid relationship. We do not edit reviews to change their meaning. Disclosure policy.

Tier A

Independent deep reviews, lab tests, certificates of analysis

Our strongest external evidence. Long-form independent reviews, physical-product lab work, and third-party certifications.

BetterVitals — NOVOS Core review 2026
unknown Not a paid placement

Structured review of the NOVOS Core stack. Formulation logic praised; notes the lack of an independent human outcome trial on the finished blend and the sponsor funding of NOVOS' own study.

How we use it: Facts on formulation, dose, and study design adopted. Editorial score not adopted.
Longevity Graded — NOVOS Core review
unknown Not a paid placement

Independent review that reaches the same conclusion: NOVOS Core's own study is sponsor-funded and unreplicated; ingredient logic is sound but no product-level outcome trial exists.

How we use it: Confirmatory Tier A source alongside BetterVitals.

Community threads and aggregate ratings

Additional public mentions we located, kept separate from the deep independent reviews above.

Reddit r/longevity
mixed

Fine as a standard NMN; users often compare it to DoNotAge and ProHealth for price.

Read source → Unverified · we received no payment for this listing
Layer 3 · Evidence vault

Evidence, claims & regulation

Published evidence, claim checks, regulatory status and what could not be verified.

Evidence, what actually backs this product

Longevity brands rarely test their exact finished product. We separate what's tested from what's inferred.

Strongest evidence tier
Tier 3Ingredient RCT (matching dose)
5 studies mapped
Tier 3Ingredient RCT (matching dose)
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Yoshino M, Yoshino J, Kayser BD, et al. · 2021 · Science, 372(6547):1224-1229 · n=25 · 250 mg/day NMN · 10 weeks
NMN significantly increased insulin-stimulated glucose disposal and skeletal muscle insulin sensitivity/signaling versus placebo; no significant change in body composition or blood pressure.
This is the single most important human NMN RCT in the field and its 250 mg/day dose is an exact match for NOVOS Boost's standard 2-capsule serving — a genuinely favorable dose-match, unlike many competing NMN products marketed at much higher doses than they've actually studied.
Source →
Tier 3Ingredient RCT (matching dose)
Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels and alters muscle function in healthy older men
Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. · 2022 · npj Aging, 8(1):5 · 250 mg/day NMN · 6 or 12 weeks
Well tolerated with no significant adverse effects; significantly increased whole-blood NAD+ metabolome levels and produced some improvements in skeletal muscle function measures.
Second matching-dose (250 mg/day) human RCT, reinforcing that NOVOS Boost's standard serving aligns with the two most-cited NMN human trials for safety and NAD+ elevation.
Source →
Tier 3Ingredient RCT (matching dose)
The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
Multiple authors (dose-ranging trial) · 2023 · GeroScience, 45(1):29-43 · Multiple arms including 300 mg, 600 mg, and 900 mg/day NMN · 60 days
Dose-dependent improvements in physical performance measures (e.g., walking distance/endurance) were reported in higher-dose arms (600-900 mg), which is the likely source of NOVOS Boost's marketing claim about '67% of users' seeing enhanced endurance — that data point applies to the 600 mg and 900 mg groups combined, not to NOVOS Boost's standard 250 mg serving.
Important dose-mismatch: NOVOS Boost's marketing page attributes the '67% enhanced endurance by day 30' finding to NMN broadly, but the underlying trial reports this specifically for the 600 mg and 900 mg dose groups — 2.4x to 3.6x higher than NOVOS Boost's labeled 250 mg daily serving. A consumer taking the standard 2-capsule dose should not expect the same endurance effect reported for the higher-dose study arms.
Source →
Tier 4Ingredient RCT (different dose)
Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and NAD+ biosynthesis in healthy, middle-aged Japanese men
Yamaguchi S, Irie J, Mitsuishi M, et al. · 2024 · Endocrine Journal, 71(2):153-169 · n=25 · 125 mg/day NMN (roughly half of NOVOS Boost's default 250 mg serving) · 8-12 weeks
Increased NAD+ in peripheral blood mononuclear cells and reductions in fasting insulin/glucose; no significant change in sleep quality measures.
Often cited alongside Yoshino/Igarashi, but this study used half of NOVOS Boost's standard daily dose (125 mg, i.e. one capsule), so it supports the low end of the product's dosing range rather than the full 2-capsule serving.
Source →
Tier 4Ingredient RCT (different dose)
Telomere length study cited by NOVOS re: 300 mg/day NMN nearly doubling telomere length over 90 days
Not independently verified to a specific indexed PubMed record from available sourcing · None · Cited by NOVOS as a study reference; we could not independently confirm the exact peer-reviewed source or its methodology in this review · 300 mg/day NMN · 90 days
NOVOS reports a ~90% increase in peripheral blood mononuclear cell telomere length.
We flag this claim as unverified in this dossier because we could not locate and directly confirm the specific underlying peer-reviewed publication independent of NOVOS's own marketing citation. Telomere length changes of this magnitude over 90 days would be a remarkable and field-shifting finding if independently replicated, which raises our skepticism bar. Additionally, the cited dose (300 mg) exceeds NOVOS Boost's standard 250 mg serving.
Source →
Evidence

Research behind this product

The studies that established the trial dose and evidence grade for each active ingredient in this product. Click through to read the original paper.

NMNYi et al. 2023 (GeroScience)
NMNOkabe et al. 2022 (Frontiers in Nutrition)
NMNUthever RCT 2022
NMNNMN meta-analysis 2024 (12 RCTs)
NMNZhang et al. 2026 meta-analysis (Nutrients)

Claim check, vendor claims vs. our reading of the evidence

Not medical advice. We list the strongest claims made by the brand and check each against traceable evidence.

Supported, at a lower dose than this product
“250 mg NMN 'supports cellular repair and DNA protection' and boosts NAD+ (implying meaningful clinical benefit at the labeled dose)”
250 mg/day is directly supported by two solid human RCTs (Yoshino 2021, Igarashi 2022) for raising NAD+ metabolites and improving specific metabolic markers, but those trials did not test or confirm broad claims like 'DNA protection' as a clinical outcome — that language extrapolates beyond what the cited studies actually measured.
Vendor source
Unsupported At Labeled Dose
“67% of NMN users saw enhanced endurance by day 30 (up to 38% increase in walking distance)”
The underlying dose-ranging trial (GeroScience 2023) reports this finding specifically for the 600 mg and 900 mg NMN dose arms — 2.4x to 3.6x higher than NOVOS Boost's standard 250 mg serving. A customer taking the labeled 2-capsule dose is not taking the dose that produced this result.
Vendor source
No evidence
“90% increase in telomere length with 300 mg/day NMN over 90 days”
We could not independently verify this specific study or its methodology from available sourcing, and the cited dose (300 mg) exceeds the product's standard 250 mg serving. A 90% telomere length increase in 90 days would be an extraordinary and heavily-scrutinized finding if properly published and replicated; treat this claim with significant skepticism pending independent verification.
Vendor source
Supported
“25% improvement in muscle insulin sensitivity after 10 weeks”
This accurately reflects the Yoshino 2021 Science paper's findings at the 250 mg/day dose over 10 weeks in postmenopausal prediabetic women — one of the few NMN marketing claims across the industry that is both dose-matched and population-specific in its sourcing.
Vendor source

Regulatory status

Rules change often. We record when we last verified each row. See the full regulatory timeline →

US
Legal As Supplement After Reversal
The FDA had excluded NMN from the dietary supplement definition in November 2022 due to prior investigational-new-drug status, but reversed this position in two letters dated September 29, 2025, confirming NMN is not excluded from the supplement definition and restoring its New Dietary Ingredient pathway. As of this review, NMN products including NOVOS Boost are considered lawfully marketable supplements again in the US, following roughly three years of regulatory limbo driven by a Natural Products Association petition and lawsuit.
Last verified 2026-08-05
EU
Novel Food, not cleared
NMN remains classified as an unauthorized Novel Food under EU Regulation 2015/2283; applications have been pending since 2022-2024 without a final EFSA opinion specific to NOVOS's ingredient supplier, though EFSA issued a positive safety opinion on a different named branded NMN ingredient (EffePharm's, at up to 300 mg/day) in 2026, which could pave the way for eventual approval of the category. Sale into the EU remains a grey-market/enforcement-varies situation.
Last verified 2026-08-05
UK
Novel Food Under Assessment But Sold Openly
The UK FSA lists NMN as a novel food under assessment (not yet formally authorized), but transitional arrangements and inconsistent enforcement mean NMN products, including NOVOS Boost, continue to be sold and shipped to UK customers without apparent legal action against sellers.
Last verified 2026-08-05
CA
Unauthorized No Npn
As of early-to-mid 2026, Health Canada had not issued a Natural Product Number (NPN) for NOVOS Boost specifically. Other companies' NMN products with different formulations have obtained NPNs (e.g., NPN 80115992-family licenses permitting 125-500 mg/day claims limited to 'source of NMN' and antioxidant statements), but NOVOS Boost was not confirmed among licensed listings we could access.
Last verified 2026-08-05

What we could not verify

We list this openly. If a claim isn't backed by a source we can trace, we'd rather flag it than repeat it.

  • The specific peer-reviewed source and full methodology for the '90% increase in telomere length' claim.
  • Whether NOVOS's NMN supplier/ingredient has received a Health Canada NPN or completed any EU/UK novel food authorization since this review.
  • Whether the 'two independent third-party labs' NOVOS references for NMN purity testing represent current, ongoing batch testing versus a one-time historical validation (the publicly linked CoA PDF is dated to 2021).
  • Trustpilot aggregator
    3.7/5108 reviews

    This is a brand-level customer-service profile for novos; it does not isolate NOVOS Boost.

    verified 2026-08-07Open source →
  • Reddit r/Supplements community forum
    mixed sentiment

    Community discussion exists around NOVOS Boost, with questions about its legitimacy and reviews alongside reports of trying the supplement. No single Reddit thread is treated as a representative product review.

    no direct URLchecked 2026-08-07
Important to know
NMNAbsorption varies wildly by form. Sublingual and liposomal claim better uptake but human head-to-head data is limited.

Editorial notes

Pure NMN in capsule form.

Go deeper

Where this sits

Actives inside
NMN
Category
See all in NAD+ booster →
Ranking
See top 10 NMN supplements →
Brand
NOVOS Labs profile →
Add to compare Visit brand site →
Brand owners

Spot an error?

If you are the manufacturer or brand owner of NOVOS Boost and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.

We review every request, verify it against primary sources, and publish any accepted change with a dated note. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.

Request a correction →
Same shelf

Similar products

All NAD+ booster →

The next highest-scoring products in NAD+ booster, same scoring method, same rules.

Renue By Science
NMN Pure Powder (Sublingual)
NAD+ booster
Precursor per serving
NMN 500 mgPowder · 200 servings
Price per serving
$0.32$64.95 · 200 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.3/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$0.32
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with renuebyscience.com
DoNotAge
Pure NR
NAD+ booster
Precursor per serving
NR 500 mgPowder · 30 servings
Price per serving
$1.83$55.00 · 30 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.1/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$1.10
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with donotage.org
NAD+ booster
Precursor per serving
NMN 250 mgCapsule · 90 servings
Price per serving
$0.56$49.99 · 90 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.1/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$1.11
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with nootropicsdepot.com
Same maker

Other products from NOVOS Labs

Brand profile →
NOVOS Labs
NOVOS Vital
Multi/greens
Ingredients listed
1 ingredients listedlargest listed: Prebiotic Fiber 4,000 mg
Price per serving
$2.30$69.00 · 30 servings
Testing
3rd-party listed · no public lab certificate

Multi-ingredient bundle

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 7.2/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$2.88
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with novoslabs.com
NOVOS Labs
NOVOS Core
Longevity stack
Ingredients listed
12 ingredients listedlargest listed: Glycine 1,000 mg
Price per serving
$2.97$89.00 · 30 servings
Testing
3rd-party listed · no public lab certificate

Multi-ingredient bundle

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 5.5/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

50%
of trial dose
$14.83
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with novoslabs.com
NOVOS Labs
NOVOS Bar
Multi/greens
Ingredients listed
3 ingredients listedlargest listed: Taurine 1,500 mg
Price per serving
$4.00$48.00 · 12 servings
Testing
None listed

Multi-ingredient bundle

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 4.8/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$8.00
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with novoslabs.com